Obstetrics & Gynecology Doctors in Campbellsville, KY Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Aaron D Stewart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 105 Greenbriar Dr Ste B, Campbellsville, KY 42718 Phone: 270-465-3568

Dr. Whitney Lynn Shepard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 105 Greenbriar Dr Ste B, Campbellsville, KY 42718 Phone: 270-465-3568

Ms. Kimberly Wurth-frazier, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 105 Greenbriar Dr Ste B, Campbellsville, KY 42718 Phone: 270-465-3568

Dr. Susan M Burress, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 105 Greenbriar Dr Ste B, Campbellsville, KY 42718 Phone: 270-465-3568

Gina S Bell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1698 Old Lebanon Rd, Suite 2b, Campbellsville, KY 42718 Phone: 270-465-3561    Fax: 270-789-6119

Steve Junior Vanmeter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1698 Old Lebanon Rd, Ste 2b, Campbellsville, KY 42718 Phone: 270-465-3568    Fax: 270-465-3115

News Archive

Top NAU microbiologist joins Arizona COVID-19 Genomics Union

The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University and the Ecology and Evolutionary Biology Department at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.

Scientists track rare potent antibodies in HIV-infected individual

One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.

SEC completes investigation of PharmaNet Development, no action recommended

PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.

Researchers use human stem cell models to analyze degeneration in glaucoma

More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.

Framing the concept of a gene

Even scientists define 'a gene' in different ways, so it comes as little surprise that the media also have various ways of framing the concept of a gene, according to a new study appearing in the October 2008 issue of EMBO reports.

Read more Medical News

› Verified 2 days ago